Advanstar Communications The Leader in Conferences for the Pharmaceutical Industry

Order Compendia

Track Two: Ensure Compliant Messaging to External Stakeholders from Commercial and Medical Teams

•   What is the difference between off-label prescribing (permitted) and off-label marketing (not permitted)?
•   Appropriate use of medical literature — When does discussion of medical efficacy for non-approved uses cross over to off-label marketing?
•   Use of prescribing physicians on medical expert panels — What are the potential pitfalls?

Ellyn L. Sternfield

Of Counsel

Mintz Levin

Share Links

Media Partners

Testimonials

This conference clearly showed that collaboration within organizations and with customers is the key to successful commercialization of products and devices - and demonstrated how to achieve success.

Todd Berner

Senior Field Scientist, Health Outcomes and Pharmacoeconomics (HOPE) Research and Development, Endo Pharmaceuticals

There are many real world examples and best practices provided in this forum. Any marketer could implement the strategies presented during this conference and immediately impact their current performance.

Boris Velinov

Product Director,Allergan

I found the topics right on and the speakers extremely knowledgeable. This was a very informative session.

Al Swarts

President, Bio-Ops, Inc.

Our company has a very strong product development process. This conference provides us with the tools to build a superior product launch process.

Onne Ganel

Director, Edwards LifeSciences

Good mix of topics and subject matter experts.

Rich Keenan

Sr. Director Vaccines, Launch Excellence, GSK

The selection of presenters was exquisite and this made their expertise evident and the content believable.

Trevor Subero

IBA Molecular

Reproduction in whole or in part is prohibited. Please send any technical comments or questions to our webmaster.